Boost your inner glow and optimize your output with these IV drips to prep you pre-summer and post-summer shine.

Merck (NYSE:MRK) marked a major milestone in its bid to introduce a new formulation for its famous cancer therapy ...

- VY1706 is the fifth neuro gene therapy development candidate nominated leveraging Voyager’s IV-delivered, CNS-penetrant TRACER capsids - ...

What happened next: Doctors found that several of the man's organs had begun to fail, and his blood tested positive for ...

It is Pfizer's second haemophilia product approval this year, coming after its one-shot haemophilia B gene therapy ...

The company is looking to score an FDA nod for its investigational therapy that targets a molecule linked to Guillain-Barré ...

A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...

Metagenomi is preparing to initiate IND-enabling activities that seek to support MGX-001’s transition from preclinical to ...

SHANGHAI, China I 19, 2024 I Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, ...

"This is the last chapter — if I get another 30, what do I want to do? My mother made it to 97," the actor said.

Kelly's acquisition of Children's Therapy Center (CTC) further expands growth opportunities in the high-margin, high-demand ...

OXFORD, UK I 19, 2024 I Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, has dosed the first ...